ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids KR Bowles, MC Silva, K Whitney, T Bertucci, JE Berlind, JD Lai, JC Garza, ... Cell 184 (17), 4547-4563. e17, 2021 | 111 | 2021 |
Advanced glycation end products (AGEs) induce apoptosis via a novel pathway: involvement of Ca2+ mediated by interleukin-8 protein S Mahali, N Raviprakash, PB Raghavendra, SK Manna Journal of Biological Chemistry 286 (40), 34903-34913, 2011 | 72 | 2011 |
Advanced Glycation End Products Induce Lipogenesis: Regulation by Natural Xanthone through Inhibition of ERK and NF‐κB SK Mahali, N Verma, SK Manna Journal of cellular physiology 229 (12), 1972-1980, 2014 | 33 | 2014 |
Glioblastoma multiforme: novel therapeutic approaches AM Fialho, P Salunkhe, S Manna, S Mahali, AM Chakrabarty International Scholarly Research Notices 2012 (1), 642345, 2012 | 30 | 2012 |
A natural xanthone increases catalase activity but decreases NF-kappa B and lipid peroxidation in U-937 and HepG2 cell lines BK Sahoo, AH Zaidi, P Gupta, RB Mokhamatam, N Raviprakash, ... European journal of pharmacology 764, 520-528, 2015 | 29 | 2015 |
Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation Acta Neuropathologica, 2023 | 25* | 2023 |
Beta-D-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding SK Mahali, SK Manna Biochemical pharmacology 84 (12), 1681-1690, 2012 | 23 | 2012 |
Conserved gene signatures shared among MAPT mutations reveal defects in calcium signaling MA Minaya, S Mahali, AK Iyer, AM Eteleeb, R Martinez, G Huang, J Budde, ... Frontiers in Molecular Biosciences 10, 1051494, 2023 | 11 | 2023 |
Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration S Mahali, R Martinez, M King, A Verbeck, O Harari, BA Benitez, K Horie, ... Translational psychiatry 12 (1), 508, 2022 | 9 | 2022 |
Defective proteostasis in patient-derived iPSC-astrocytes and neurons carrying a MAPT IVS10+ 16 mutation S Mahali, C Karch Alzheimers Dement 17 (e054448), 2021 | 3 | 2021 |
Anticancer agent A Suri, D Kanojia, P Salunkhe, S Mahali, SK Manna, A Surolia, ... US Patent 9,624,277, 2017 | 2 | 2017 |
Defective proteostasis in patient-derived iPSC-astrocytes and neurons carrying a MAPT IVS10+16 mutation Annual Hope Center Retreat, 2022 | | 2022 |
KIF18A plus end spatio-temporal regulation by Aurora B & PP1 during (pro)- metaphase is required for proper mitosis S Mahali, B Lesage, GVD Hoeven, M Beullens, M Bollen Researchgate, 2022 | | 2022 |
Lysosomal Dysfunction in Stem Cell Models of Tauopathy CM Karch, S Mahali, S Jiang, S Hsu, B Benitez, O Harari, C Cruchaga ANNALS OF NEUROLOGY 86, S147-S148, 2019 | | 2019 |
O3‐07‐02: LYSOSOMAL DYSFUNCTION IN STEM CELL MODELS OF TAUOPATHY S Mahali, S Jiang, S Hsu, B Benitez, O Harari, C Cruchaga, CM Karch Alzheimer's & Dementia 15, P897-P898, 2019 | | 2019 |
O2‐12‐01: LYSOSOMAL DYSFUNCTION AND ALTERED TAU METABOLISM IN STEM CELL MODELS OF AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE S Mahali, S Hsu, B Benitez, R Martinez, AM Goate, C Karch, DIAN Alzheimer's & Dementia 14 (7S_Part_12), P650-P650, 2018 | | 2018 |
Understanding advanced glycation end product-mediated cell signaling and its regulation SK Mahali Manipal, 0 | | |